Multidrug-resistance and extended spectrum beta-lactamase production in uropathogenic E. coli which were isolated from hospitalized patients in Kolkata, India

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 3, 2013, Pages 449-453

  Mukherjee, Mandira ^a   Basu, Shreya ^a   MuKherjee, Sandip KuMar ^a   Majumder, Monalisa ^a  

^a CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

Author keywords

Antibiotic susceptibility; Extended spectrum beta lactamase; Urinary tract infection; Uropathogenic E. coli

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; BETA LACTAMASE; CEFALEXIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; LEVOFLOXACIN; LOMEFLOXACIN; NALIDIXIC ACID; NITROFURANTOIN; OFLOXACIN; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; DISK DIFFUSION; DRUG SENSITIVITY; HOSPITAL PATIENT; INDIA; MULTIDRUG RESISTANCE; NONHUMAN; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84874905816     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2013/4990.2796     Document Type: Article

References (19)

1. Khan AU, Zaman MS. Multiple drug resistance pattern in Urinary Tract Infection patients in Aligarh. Biomed. Res. 2006; 17 (3): 179-181.
2. Ramazanzadeh R. Etiologic agents and extended-spectrum beta-lactamase production in urinary tract infections in Sanandaj, Iran. Eastern J. Med. 2010; 15: 57-62.
3. Aggarwal R, Chaudhary U, Sikka R. Detection of extended spectrum β-lactamase production among uropathogens. J. Lab. Physicians. 2009; 1(1): 7-10.
4. Sood, S, Gupta R. Antibiotic resistance pattern of community acquired uropathogens at a tertiary care hospital in Jaipur, Rajasthan. Indian J. Community Med. 2012; 37(1): 39-44.
5. Myer, Koshi. Methods in biochemical identifcation of bacteria. Myer's and Koshi's manual of diagnostic procedures in medical microbiology and immunology/ serology, 2nd ed. Vellore: Department of Clinical Microbiology, Christian Medical College. 2001;195-202.
6. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. (2010) CLSI document M100-S21. Wayne, PA: Clinical and Laboratory Standards Institute, 1.
7. Soto SM, Jimenez de Anta MT, Vila J. Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli by SOS-dependent or -independent pathways, respectively. Antimicrob. Agents Chemother. 2006; 50(2):649-653.
8. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin. Infect. Dis., 2001; 33: 757-762.
9. Linder JA, Huang ES, Steinman MA, Gonzales R, Stafford RS. Fluoroquinolone prescribing in the United States: 1995 to 2002. Am J Med. 2005; 118: 259-268.
10. Rijavec M, Starcic Erjavec M, Ambrozic Avgustin J, Reissbrodt R, Fruth A, Krizan-Hergouth V, et al. High prevalence of multidrug resistance and random distribution of mobile genetic elements among uropathogenic Escherichia coli (UPEC) of the four major phylogenetic groups. Curr. Microbiol. 2006; 53(2): 158-162.
11. Das RN, Chandrashekhar TS, Joshi HS, Gurung M, Shrestha N, Shivananda PG. Frequency and susceptibility profle of pathogens causing urinary tract infections at a tertiary care hospital in western Nepal. Singapore Med. J. 2006; 47(4): 281-285.
12. Peripi SB, Thadepalli VG, Khagga M, Tripuraribhatla PK, Bharadwaj DK. Profile of antibiotic consumption, sensitivity and resistance in an urban area of Andhra Pradesh, India. Singapore Med. J. 2012; 53(4): 268-272.
13. Wolff O, Maclennan C. Evidence behind the WHO guidelines hospital care for children: What is the appropriate empiric antibiotic therapy in uncomplicated urinary tract infection in children in developing countries? J. Trop. Ped. 2007; 53: 150-152.
14. Farshad S, Ranjbar R, Japoni A, Hosseini M, Anvarinejad M, Mohammadzadegan R. Microbial susceptibility, virulence factors, and plasmid profles of uropathogenic Escherichia coli strains isolated from children in Jahrom, Iran. Arch. Iran Med. 2012; 15(5): 312-316.
15. Shao HF, Wang W P, Zhang XW, Li ZD. Distribution and resistance trends of pathogens from urinary tract infections and impact on management. Internal. J. Antimicrob. Agents. 2004; 23: 2-5.
16. Naseer U, Sundsfjord A The CTX-M conundrum: dissemination of plasmids and Escherichia coli clones. Microb Drug Resist. 2011; 17: 83-97.
17. Luzzaro F, Mezzatesta M, Mugnaioli C, Perilli M., Stefani S., Amicosante G et al. Trends in production of extended-spectrum beta-lactamases among enterobacteria of medical interest: report of the second Italian nationwide survey. J. Clin. Microbiol. 2006; 44: 1659-1664.
18. Bhattacharya S. Is screening patients for antibiotic-resistant bacteria justifed in the Indian context? Indian J. Med Microbiol. 2011; 29(3): 213-217.
19. Subbalaxmi M V, Lakshmi V, Lavanya V. Antibiotic resistance -experience in a tertiary care hospital in South India. J. Assoc. Physicians. India. 2010; 58 Suppl:18-22.